CFDE Data Portal | Search IGLL3P

	Label	Description
	IGLL3P associations Collection (Entity type)	Associations for IGLL3P_associations
	IGLL3P associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	IGLL3P Gene (Entity type)	ENSG00000285968 - immunoglobulin lambda like polypeptide 3, pseudogene
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE192362 erastin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	PDIK1L IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE230865 EYA2 knockdown 3 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

IGLL3P associations

Associations for IGLL3P_associations

IGLL3P associations.tsv

A file from IDG as part of the Harmonizome project

IGLL3P

ENSG00000285968 - immunoglobulin lambda like polypeptide 3, pseudogene

GSE169617 azacitidine 1 v 2 human up

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 8 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 6 human dn

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human dn

A Gene Set from LINCS

GSE192362 erastin 1 v 0 human dn

A Gene Set from LINCS

PDIK1L IDG kinase ARCHS4 coexpression

A Gene Set from IDG

GSE230865 EYA2 knockdown 3 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.